JPH0459298B2 - - Google Patents

Info

Publication number
JPH0459298B2
JPH0459298B2 JP12942681A JP12942681A JPH0459298B2 JP H0459298 B2 JPH0459298 B2 JP H0459298B2 JP 12942681 A JP12942681 A JP 12942681A JP 12942681 A JP12942681 A JP 12942681A JP H0459298 B2 JPH0459298 B2 JP H0459298B2
Authority
JP
Japan
Prior art keywords
vitamin
hydroxyvitamin
cells
epidioxy
hydroxyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP12942681A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5832823A (ja
Inventor
Tatsuo Suda
Koji Mizuno
Shinichi Kaiho
Fusayo Onoda
Kyoshige Ochi
Isao Matsunaga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Priority to JP12942681A priority Critical patent/JPS5832823A/ja
Publication of JPS5832823A publication Critical patent/JPS5832823A/ja
Publication of JPH0459298B2 publication Critical patent/JPH0459298B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP12942681A 1981-08-20 1981-08-20 脱癌剤 Granted JPS5832823A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP12942681A JPS5832823A (ja) 1981-08-20 1981-08-20 脱癌剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP12942681A JPS5832823A (ja) 1981-08-20 1981-08-20 脱癌剤

Publications (2)

Publication Number Publication Date
JPS5832823A JPS5832823A (ja) 1983-02-25
JPH0459298B2 true JPH0459298B2 (enrdf_load_html_response) 1992-09-21

Family

ID=15009196

Family Applications (1)

Application Number Title Priority Date Filing Date
JP12942681A Granted JPS5832823A (ja) 1981-08-20 1981-08-20 脱癌剤

Country Status (1)

Country Link
JP (1) JPS5832823A (enrdf_load_html_response)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58206521A (ja) * 1982-05-26 1983-12-01 Kureha Chem Ind Co Ltd 抗腫瘍剤
JPS58206522A (ja) * 1982-05-26 1983-12-01 Kureha Chem Ind Co Ltd 抗腫瘍剤
JPS58206523A (ja) * 1982-05-26 1983-12-01 Kureha Chem Ind Co Ltd 抗腫瘍剤
JPS58206524A (ja) * 1982-05-26 1983-12-01 Kureha Chem Ind Co Ltd 抗腫瘍剤
JPS58206525A (ja) * 1982-05-26 1983-12-01 Kureha Chem Ind Co Ltd 抗腫瘍剤
JPS58206526A (ja) * 1982-05-26 1983-12-01 Kureha Chem Ind Co Ltd 抗腫瘍剤
JPS58208229A (ja) * 1982-05-28 1983-12-03 Kureha Chem Ind Co Ltd 抗腫瘍剤
JPS58208225A (ja) * 1982-05-28 1983-12-03 Kureha Chem Ind Co Ltd 抗腫瘍剤
JPS58210020A (ja) * 1982-05-31 1983-12-07 Kureha Chem Ind Co Ltd 抗腫瘍剤
JPS58210018A (ja) * 1982-05-31 1983-12-07 Kureha Chem Ind Co Ltd 抗腫瘍剤
JPS58210015A (ja) * 1982-05-31 1983-12-07 Kureha Chem Ind Co Ltd 抗腫瘍剤
JPS58210014A (ja) * 1982-05-31 1983-12-07 Kureha Chem Ind Co Ltd 抗腫瘍剤
SI3095447T1 (sl) * 2006-02-03 2022-02-28 Opko Renal, Llc Zdravljenje pomanjkanja vitamina D s 25-hidroksivitaminom D2 in 25-hidroksivitaminom D3
WO2008008608A2 (en) 2006-06-21 2008-01-17 Proventiv Therapeutics, Llc Method of treating and preventing secondary hyperparathyroidism
ES2403107T3 (es) * 2007-04-25 2013-05-14 Cytochroma Inc. Método de tratamiento de insuficiencia y deficiencia de vitamina D
EP3342405B1 (en) 2007-04-25 2019-08-21 Opko Ireland Global Holdings, Ltd. Controlled release 25-hydroxyvitamin d
DK3225243T3 (da) 2007-04-25 2025-09-29 Opko Renal Llc Metode til sikker og effektiv behandling og forebyggelse af sekundær hyperparatyreoidisme ved kronisk nyresygdom
EP2281058B1 (en) 2008-04-02 2016-06-29 Opko Ireland Global Holdings, Ltd. Methods, compositions, uses, and kits useful for vitamin d deficiency and related disorders
CA2797537C (en) 2010-03-29 2021-11-23 Cytochroma Inc. Use of 25-hydroxyvitamin d compound for reducing parathyroid levels
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
KR20230054752A (ko) 2016-03-28 2023-04-25 옵코 아일랜드 글로벌 홀딩스 리미티드 비타민 d 치료 방법

Also Published As

Publication number Publication date
JPS5832823A (ja) 1983-02-25

Similar Documents

Publication Publication Date Title
JPH0459298B2 (enrdf_load_html_response)
EP0202276B1 (en) Composition for the treatment of psoriasis
JP2004535429A (ja) 活性なビタミンｄ類縁体を使用する異常増殖性疾患の治療方法
JP2001511768A (ja) 活性型ビタミンｄ類似体を使用した前立腺疾患の治療方法
PT99998B (pt) Metodo para a preparacao e utilizacao da 1-alfa,24-di-hidroxi-vitamina d2
JPS6365646B2 (enrdf_load_html_response)
DE69011872T2 (de) Neue vitamin-d-derivate.
JP2004535439A (ja) 活性なビタミンｄ類縁体を使用する悪性関連高カルシウム血症の治療方法
JPH07500848A (ja) １α，２４（Ｓ）−ジヒドロキシビタミンＤ↓２の調製及び使用方法
DE69608701T2 (de) Vitamin d analoge
DE69706241T2 (de) Pharmazeutische Zusammensetzung zur Behandlung der Leukämie enthaltend 9-cis-Retinoinsäure-alpha-Tocopherolester
RU2133738C1 (ru) 1,25-диокси-16-ен-24-оксо-холекальциферол или 1,24,25-триокси-16-ен- холекальциферол
DE69732369T2 (de) Vitamin d3-derivate
JPH0780773B2 (ja) 新規ビタミンｄ▲下３▼誘導体を有効成分とする医薬
US5397776A (en) Vitamin D compounds with anti-progesterone activity
JP2522962B2 (ja) 乾癬治療剤
ES2241182T3 (es) Procedimiento de inhibicion de la produccion de citocinas.
EP1178960A1 (en) Vitamin d analogues and their pharmaceutical use
US20200000789A1 (en) Vacuole-inducing compounds, methods of making and using the same
JP3567223B2 (ja) カルシウム代謝改善剤
JPH0220613B2 (enrdf_load_html_response)
JPH0525049A (ja) 安定な１α―ヒドロキシビタミンＤ類製剤
JPS58210017A (ja) 抗腫瘍剤
JPS58210010A (ja) 抗腫瘍剤
JPH0813744B2 (ja) ９，１０−セコ−５，７，１０（１９）−プレグナトリエン誘導体を有効成分とする医薬